You are here

Restasis

AbbVie's blockbuster eye drug Restasis under threat as FDA approves Viatris' copycat

Fierce Pharma

Wed, 02/2/22 - 11:50 pm

AbbVie revives DTC ads for dry eye med Restasis with a patient front and center

Fierce Pharma

Mon, 04/26/21 - 10:48 am

dry eye disease

DTC advertising

Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray

Endpoints

Mon, 05/11/20 - 10:36 am

Oyster Point Pharma

dry eye disease

Supreme Court sends Allergan packing over Restasis tribal licensing strategy

Fierce Pharma

Mon, 04/15/19 - 11:51 pm

Aurinia eye drug falls short in improving tolerability versus Restasis, but beats on efficacy

Endpoints

Tue, 01/22/19 - 11:43 am

Aurinia Pharmaceuticals

dry eye disease

Allergan nixes Texas plant expansion as Restasis generics loom

Fierce Pharma

Mon, 11/5/18 - 07:23 pm

drug manufacturing

Allergan, Mohawk tribe request rehearing in sovereign immunity IPR case

BioCentury

Fri, 08/24/18 - 10:26 pm

Federal judges ban Allergan’s sovereign immunity scheme in a slapdown that will bolster inter partes review for years to come

Endpoints

Sat, 07/21/18 - 02:03 pm

inter partes review

Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug

Endpoints

Thu, 07/12/18 - 11:49 am

dry eye disease

Allergan: This $64,000 Question Could Kill Restasis IPR Appeal

NY Shock Exchange

Thu, 06/28/18 - 09:28 am

Allergan: Restasis Lawsuit From Kroger, Walgreens Could Cost Billions

NY Shock Exchange

Thu, 06/14/18 - 06:48 pm

Allergan faces fresh woes with Restasis patents as Walgreen, retailers file lawsuit over ‘anticompetitive conduct’

Endpoints

Fri, 05/18/18 - 09:33 pm

Allergan's much-maligned tribal licensing deal wins reprieve at appeals court

Fierce Pharma

Thu, 03/29/18 - 10:36 pm

Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire

Xtalks

Wed, 03/21/18 - 10:55 am

dry eye disease

Tribe looks to stop patent board’s review of Restasis IP

Drug Delivery Business News

Tue, 03/20/18 - 11:13 am

intellectual property

Senators heap abuse on Allergan’s attempt at an end run around patent reviews, offer bill to stop ‘sham’

Endpoints

Fri, 03/9/18 - 11:05 am

inter partes review

Sovereign nonsense: Patent board joins the lineup of critics dissing Allergan’s ‘illusory’ IP deal with the Mohawks

Endpoints

Mon, 02/26/18 - 11:04 pm

Don't expect Restasis generics till at least next quarter, Allergan CEO says

Fierce Pharma

Tue, 01/9/18 - 10:52 pm

FDA Denies 3rd Allergan Citizen Petition to Block Restasis Generics

RAPS.org

Thu, 01/4/18 - 09:41 pm

citizen petitions

Allergan axing 1,000-plus jobs, prepping for a painful onslaught of Restasis knockoffs

Endpoints

Thu, 01/4/18 - 12:15 am

Pages